# OnCo record nct04616209 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04616209/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04616209", "NCT04616209" ;
  schema:name "Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) Patients"@en ;
  schema:description "A phase 1/2 trial of donor-derived NK cell infusion in non-small-cell lung cancer, run by Precision Biotech Taiwan Corp., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04616209/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04616209> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2020-11-15" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> .